RINGER ELSaad
-
Chemical Name:
Nacl+ Kcl 300 +Cacl3 -
Therapeutic Category:
Fluids and Electrolytes -
Pharmacologic Category:
Electrolyte Supplement, Parenteral -
Pharmaceutical Form:
Serum -
Composition:
(Nacl 8.6mg + Kcl 300mg +Cacl3 300mg) / liter
Ringer
injection solution
1-CLINICAL PHARMACOLOGY:
Ringer's Injection provides electrolytes and is a source of water for hydration. It is capable of inducing diuresis depending on the clinical condition of the patient.
Sodium, the major cation of the extracellular fluid, functions primarily in the control of water distribution, fluid balance, and osmotic pressure of body fluids. Sodium is also associated with chloride and bicarbonate in the regulation of the acid-base equilibrium of body fluid. Potassium, the principal cation of intracellular fluid, participates in carbohydrate utilization and protein synthesis, and is critical in the regulation of nerve conduction and muscle contraction, particularly in the heart.
Chloride, the major extracellular anion, closely follows the metabolism of sodium, and changes in the acid-base balance of the body are reflected by changes in the chloride concentration. Calcium, an important cation, provides the framework of bones and teeth in the form of calcium phosphate and calcium carbonate. In the ionized form, calcium is essential for the functional mechanism of the clotting of blood, normal cardiac function, and regulation of neuromuscular irritability.
2-INDICATIONS AND USAGE:
RINGER injection is indicated for use in adults and pediatric patients as a source of electrolytes and water for hydration.
3-CONTRAINDICATIONS:
RINGER injection is contraindicated where the administration of sodium, potassium, calcium, or chloride could be clinically detrimental.
4-WARNINGS:
- The administration of intravenous solutions can cause fluid and/or solute overload resulting in dilution of serum electrolyte concentrations, overhydration, congested states or pulmonary edema. The risk of dilutional states is inversely proportional to the electrolyte concentration. The risk of solute overload causing congested states with peripheral and pulmonary edema is directly proportional to the electrolyte concentration.
- Solutions containing sodium ions should be used with great care, if at all, in patients with congestive heart failure, severe renal insufficiency, and in clinical states in which there is sodium retention with edema.
- Solutions containing potassium ions should be used with great care, if at all, in patients with hyperkalemia, severe renal failure, and in conditions in which potassium retention is present.
- Solutions containing calcium ions should not be administered through the same administration set as blood because of the likelihood of coagulation.
- Sodium-containing solutions should be administered with caution to patients receiving corticosteroids or corticotrophin, or to other salt-retaining patients.
- Parenteral calcium should be administered with extreme caution to patients receiving digitalis preparations
- Potassium therapy should be guided primarily by serial electrocardiograms, especially in patients receiving digitalis.
- Clinical evaluation and periodic laboratory determinations are necessary to monitor changes in fluid balance, electrolyte concentrations, and acid base balance during prolonged parenteral therapy.
5-PREGNANCY USE:
Ringer Injection should be given to a pregnant woman only if clearly needed.
6-PEDIATRIC USE:
Safety and effectiveness of Ringer Injection in pediatric patients have not been established by adequate and well controlled trials, however, the use of electrolyte solutions in the pediatric population is referenced in the medical literature
7-GERIATRIC USE:
Dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function.
8-ADVERSE REACTIONS:
Reactions which may occur because of the solution or the technique of administration include febrile response, infection at the site of injection, venous thrombosis or phlebitis extending from the site of injection, extravasation and hypervolemia.
Hypernatremia may be associated with edema and exacerbation of congestive heart failure due to the retention of water, resulting in an expanded extracellular fluid volume.
Reactions reported with the use of potassium-containing solutions include nausea, vomiting, abdominal pain and diarrhea. The signs and symptoms of potassium intoxication include paresthesias of the extremities, areflexia, muscular or respiratory paralysis, mental confusion, weakness, hypotension, cardiac arrhythmias, heart block, electrocardiographic abnormalities and cardiac arrest. Potassium deficits result in disruption of neuromuscular function, and intestinal ileus and dilatation.
If infused in large amounts, chloride ions may cause a loss of bicarbonate ions, resulting in an acidifying effect.
Abnormally high plasma levels of calcium can result in depression, amnesia, headaches, drowsiness, disorientation, syncope, hallucinations, hypotonia of both skeletal and smooth muscles, dysphagia, arrhythmias and coma. Calcium deficits can result in neuromuscular hyperexcitability, including cramps and convulsions
9-DOSAGE AND ADMINISTRATION:
This solution is for intravenous use only.
Dosage is to be directed by a physician and is dependent upon age, weight, clinical condition of the patient and laboratory determinations.
10-PACKAGING AND COMPOSITION:
500 ml of sterile solution contains:
Sodium Chloride 0.86 %
Potassium Chloride 0.03 %
Calcium Chloride 0.033 %
11-STORAGE:
Store below 25C p